1-4 of 4
Petr Cetkovsky, MD., PhD.
Close
Sort by
Journal Articles

Hematopoietic Cell Transplantation after TBI, Fludarabine, Idarubicine and Cytarabine Myeloablative Conditioning in Patients with Acute Myeloid Leukemia

Jan Vydra, MD, Veronika Válková, MD, Markéta Šťastná Marková, MD, Ludmila Nováková, MD, Jiří Schwarz, MD PhD, Cyril Šálek, MD PhD, Antonín Vítek, MD, Petr Cetkovský, MD PhD Prof., Jaroslav Čermák, MD PhD, Kyra Michalová, Prof.
Journal: Blood
Blood (2014) 124 (21): 5847.
https://doi.org/10.1182/blood.V124.21.5847.5847
Published: 2014
Journal Articles

Clinical Manifestation of 1000 Leukemias.

Zdenek Racil, MD, PhD, Jiri Mayer, Prof., MD, PhD, Martin Brejcha, MD, Petr Cetkovsky, MD., PhD., Jirina Prochazkova, Rene Zounar
Journal: Blood
Blood (2009) 114 (22): 4134.
https://doi.org/10.1182/blood.V114.22.4134.4134
Published: 2009
Journal Articles

Molecular Variability of FLT3/ITD Mutants and Their Impact on the Differentiation Program of 32D Cells: Implications for the Biological Properties of AML Blasts

Sona Pekova, M.D., PhD., Michal Dvorak, PhD., Robert Ivanek, Sabrina Rueggeberg, Stefan Leicht, Tomas Kozak, MD, PhD, Jiri Vrba, MD., Jiri Schwarz, MD., PHD., Petr Cetkovsky, MD., PHD., Miroslav Prucha, MD., PHD., Ondrej Hrusak
Journal: Blood
Blood (2008) 112 (11): 4480.
https://doi.org/10.1182/blood.V112.11.4480.4480
Published: 2008
Journal Articles

A Limited Impact of Chemotherapy on Prolonged Survival in Myelodysplasia (MDS). An Analysis of 142 Patients with Advanced Disease.

Jaroslav Cermak, MD, PhD, Antonin Vitek, MD, Marcela Lukasova, MD, Petr Cetkovsky, MD,PhD, Pavel Klener, MD,PhD
Journal: Blood
Blood (2006) 108 (11): 2677.
https://doi.org/10.1182/blood.V108.11.2677.2677
Published: 2006